A Study of the Crestal Bone Loss Around Bone Level Versus Tissue Level Implants in Non-compliant Patients With Healthy or Reduced Periodontium After 5-8 Years in Function
A Comparative Observational Study of the Crestal Bone Loss Around Bone Level Versus Tissue Level Implants in Non-compliant Patients With Healthy or Reduced Periodontium After 5-8 Years in Function"
1 other identifier
observational
130
1 country
1
Brief Summary
The goal is to evaluate, after 5 to 8 years, the marginal bone loss around tissue-level implants and bone-level implants in patients who have not followed the maintenance program. Medical records of patients who have been implanted for at least 5 to 8 years and who have been lost during this period are collected from three private clinics in Beirut,Lebanon and the Saint Joseph University Health Center in Beirut,Lebanon. On an individual sheet, the patient as well as the implants data will be noted. Patients will be called for reevaluation after 5-8 years. After signing the informed consent, the measurements by a PCP-15 probe of the plaque index (FMPS) and the bleeding index (FMBS) as well as the height of the keratinized tissue are indicated on the sheet. If the smoking status has changed, this will be mentioned too. The marginal bone loss will be measured on the X-rays taken immediately after the implant placement, after 1 year of loading and then at the reevaluation session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 16, 2021
CompletedFirst Posted
Study publicly available on registry
June 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2022
CompletedJune 28, 2021
June 1, 2021
12 months
June 16, 2021
June 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Marginal bone loss
It will be measured mesially and distally on each implant platform until the bone's first coronal contact with the implant. Then, the total bone loss on each implant will be calculated. This is done on the software in millimeters.
5 to 8 years
Level of oral hygiene
The second factor studied is the level of hygiene which will be calculated by measuring the plaque index and bleeding on probing. This is done with a PCP-15 periodontal probe by a light sweeping movement at the level of the 4 sites of each tooth and implant and then written on the personalized card for each patient.
5 to 8 years
Secondary Outcomes (8)
Smoking status
5 to 8 years
Periodontal status
5 to 8 years
success and survival of the implant
5 to 8 years
Years in function
5 to 8 years
Height and thickness of the peri-implant keratinized mucosa
5 to 8 years
- +3 more secondary outcomes
Other Outcomes (5)
Implant position
5 to 8 years
Type of prosthesis
5 to 8 years
Surgical times
5 to 8 years
- +2 more other outcomes
Interventions
Periapical radiographs on reevaluation
Eligibility Criteria
All patients who had implants between 2012 and 2015 and who did not follow a maintenance program and whose inclusion criteria are present will be included in the study.
You may qualify if:
- Patients who have undergone the initial phase followed by implant placement in the posterior region.
- Implants placed for more than 5 years.
- The implant systems selected are:
- Tissue Level Implants: Straumann (Straumann Dental Implants System, Switzerland),
- Bone Level implants: Branemark, 3i Biomet (external and internal connection), Nobel replace and Astra.
- Patients who did not comply with the maintenance program and who missed more than 30% of appointments.
You may not qualify if:
- Systemic diseases (uncontrolled diabetes, drugs which may affect bone metabolism).
- Totally edentulous.
- Severe periodontitis not stabilized
- Inappropriate, unavailable or distorted x-rays.
- Augmented sites.
- Implants placed at a supra or infraosseous level.
- Implants placed immediately after extraction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saint Joseph University of Beirut
Beirut, Mount Lebanon, Lebanon
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
June 16, 2021
First Posted
June 28, 2021
Study Start
June 1, 2021
Primary Completion
May 29, 2022
Study Completion
July 29, 2022
Last Updated
June 28, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF